Ultomiris®
Ultomiris® (ravulizumab-cwvz) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, helping to protect healthy cells from damage.
Ultomiris® is used to treat adults with a disease called Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare genetic disorder in which defective red blood cells break down prematurely and leak hemoglobin into the blood. Ultomiris® is also used to treat adults and children 1 month of age and older with a disease called atypical Hemolytic Uremic Syndrome (aHUS).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Alexion |
CLASS: Monoclonal antibodies |
PRESCRIBED BY: Hematologists or other prescribers specifically enrolled in the Ultomiris REMS program |
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Every eight weeks, starting two weeks after an initial loading dose |
Length of infusion: Two hours in adults and up to four hours in children |
FOR MORE INFORMATION: |
